Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Unlocked slides from Wing-Kin Syn, MBChB, PhD, FACP, FRCP and CCO: How to use biomarkers and imaging to evaluate NAFLD and NASH—ruling in or out hepatic fibrosis
Expert commentary discussing the early identification and prognosis of NAFLD, from Clinical Care Options (CCO)
Unlocked slides from Manal Abdelmalek, MD, MPH, and CCO: Who is at risk and who should be evaluated for progression to advanced fibrosis in NASH?
Interactive video from Brent Tetri, MD, and CCO: impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease